Fexofenadine and Pseudoephedrine Tablets Recalled for Failed Dissolution
Dr. Reddy's Laboratories is recalling Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg Extended Release Tablets because they failed dissolution specifications, which may affect how the medication works in the body.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall for a pharmaceutical product. The hazard is a manufacturing defect (failed dissolution specifications) with no reported illnesses or injuries, making it a typical Class III case that falls in the Moderate category per the rubric.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Antihistamine & Nasal Decongestant tablets containing Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg, Extended Release, 12 Hour formulation, distributed under the brand Rugby Laboratories. The recall affects 2352 cartons with lot number AC2103329H and expiration date 1/2023.
The recall was initiated because the tablets failed to meet dissolution specifications. Dissolution specifications ensure that a tablet breaks down and releases its active ingredients at the proper rate in the body. When a tablet fails these specifications, the medication may not work as intended, potentially leaving consumers without expected allergy and congestion relief.
The affected product was distributed nationwide in the United States. Consumers who have this medication should stop using it and contact their healthcare provider or pharmacist for advice on how to proceed. The product can be returned to the point of purchase.
The recalled product
- Product
- Antihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy & Congestion, 12 Hour, 20 Tablets, Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152, www.rugbylaboratories.
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Hazard
- failed-dissolution
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AC2103329H
- Exp 1/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27